Bioventus Inc.’s BVS surgical solutions business unit sales are expected to be in focus when the company reports its third-quarter 2023 results. Bioventus’ earnings beat estimates in one of the ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

The verdict is in: Zack Snyder’s Batman v. Superman: Dawn of Justice will end up as the No. 7 comic-book movie of all time at the worldwide box office to date, not accounting for inflation. Through ...

Bioventus (BVS) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.07 per share a year ago. These figures are ...